Nektar Therapeutics (NKTR)
USD 0.49
(-10.6%)
USD 0.49
(-10.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -243.1 Million USD | 41.23% |
| 2022 | -323.87 Million USD | 51.4% |
| 2021 | -462.96 Million USD | -30.61% |
| 2020 | -394.32 Million USD | 8.69% |
| 2019 | -382.7 Million USD | -151.68% |
| 2018 | 734.3 Million USD | 3117.92% |
| 2017 | -42.52 Million USD | 74.35% |
| 2016 | -97.26 Million USD | -541.12% |
| 2015 | -29.37 Million USD | -440.67% |
| 2014 | -2.74 Million USD | 97.38% |
| 2013 | -106 Million USD | 13.96% |
| 2012 | -124.1 Million USD | -14.03% |
| 2011 | -107.78 Million USD | -4516.3% |
| 2010 | -9.33 Million USD | 103.16% |
| 2009 | -75.71 Million USD | 57.1% |
| 2008 | 2.53 Million USD | -206.01% |
| 2007 | -7.12 Million USD | 42.58% |
| 2006 | -125.72 Million USD | -37.65% |
| 2005 | -147.06 Million USD | -61.14% |
| 2004 | -54.75 Million USD | 42.74% |
| 2003 | -47.76 Million USD | 0.17% |
| 2002 | -81.11 Million USD | -199.97% |
| 2001 | -70.31 Million USD | 782.66% |
| 2000 | -53.72 Million USD | 12.72% |
| 1999 | -23.34 Million USD | 26.87% |
| 1998 | -18.39 Million USD | -62.96% |
| 1997 | -11.28 Million USD | 5.16% |
| 1996 | -10.3 Million USD | -32.22% |
| 1995 | -7.7 Million USD | -55.17% |
| 1994 | -5.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -35.02 Million USD | -49.67% |
| 2024 Q1 | -32.84 Million USD | 11.58% |
| 2023 Q4 | -29 Million USD | -1.33% |
| 2023 Q3 | -28.62 Million USD | -0.58% |
| 2023 Q2 | -28.46 Million USD | 13.7% |
| 2023 FY | - USD | 41.23% |
| 2023 Q1 | -32.98 Million USD | 12.66% |
| 2022 FY | - USD | 51.4% |
| 2022 Q4 | -37.76 Million USD | -15.33% |
| 2022 Q3 | -32.74 Million USD | 28.34% |
| 2022 Q2 | -45.69 Million USD | 58.82% |
| 2022 Q1 | -110.96 Million USD | 17.01% |
| 2021 FY | - USD | -30.61% |
| 2021 Q2 | -105.81 Million USD | -1.32% |
| 2021 Q3 | -113.46 Million USD | -7.23% |
| 2021 Q4 | -133.7 Million USD | -17.84% |
| 2021 Q1 | -104.43 Million USD | 1.15% |
| 2020 Q1 | -75.58 Million USD | 21.01% |
| 2020 Q3 | -100.14 Million USD | -44.44% |
| 2020 Q2 | -69.32 Million USD | 8.28% |
| 2020 Q4 | -105.64 Million USD | -5.5% |
| 2020 FY | - USD | 8.69% |
| 2019 Q1 | -105.12 Million USD | -23.42% |
| 2019 Q2 | -95.92 Million USD | 8.75% |
| 2019 Q3 | -87.24 Million USD | 9.05% |
| 2019 Q4 | -95.69 Million USD | -9.68% |
| 2019 FY | - USD | -151.68% |
| 2018 Q1 | -82.62 Million USD | -1947.25% |
| 2018 Q3 | -84.1 Million USD | -108.53% |
| 2018 Q2 | 985.7 Million USD | 1292.96% |
| 2018 Q4 | -85.17 Million USD | -1.28% |
| 2018 FY | - USD | 3117.92% |
| 2017 Q1 | -49.74 Million USD | -58.31% |
| 2017 Q3 | 74.87 Million USD | 250.51% |
| 2017 Q4 | -4.03 Million USD | -105.39% |
| 2017 FY | - USD | 74.35% |
| 2017 Q2 | -49.75 Million USD | -0.01% |
| 2016 Q1 | -4.89 Million USD | 83.15% |
| 2016 Q3 | -28.7 Million USD | 15.46% |
| 2016 Q4 | -31.42 Million USD | -9.48% |
| 2016 FY | - USD | -541.12% |
| 2016 Q2 | -33.94 Million USD | -593.67% |
| 2015 Q4 | -29.03 Million USD | -732.24% |
| 2015 Q2 | -40.36 Million USD | -187.31% |
| 2015 FY | - USD | -440.67% |
| 2015 Q3 | 4.59 Million USD | 111.38% |
| 2015 Q1 | 46.22 Million USD | 235.9% |
| 2014 Q1 | -32.82 Million USD | 8.29% |
| 2014 FY | - USD | 97.38% |
| 2014 Q2 | -19.56 Million USD | 40.4% |
| 2014 Q3 | 80.44 Million USD | 511.18% |
| 2014 Q4 | -34.01 Million USD | -142.28% |
| 2013 Q4 | -35.79 Million USD | -1305.89% |
| 2013 Q2 | -32.4 Million USD | 21.04% |
| 2013 FY | - USD | 13.96% |
| 2013 Q1 | -41.03 Million USD | 4.26% |
| 2013 Q3 | -2.54 Million USD | 92.14% |
| 2012 Q1 | -32.14 Million USD | -6.16% |
| 2012 FY | - USD | -14.03% |
| 2012 Q4 | -42.86 Million USD | -49.58% |
| 2012 Q3 | -28.65 Million USD | -25.2% |
| 2012 Q2 | -22.88 Million USD | 28.8% |
| 2011 Q3 | -20.71 Million USD | 30.81% |
| 2011 Q2 | -29.94 Million USD | -1.23% |
| 2011 Q4 | -30.28 Million USD | -46.17% |
| 2011 FY | - USD | -4516.3% |
| 2011 Q1 | -29.57 Million USD | -723.7% |
| 2010 Q2 | 6.44 Million USD | 413.96% |
| 2010 FY | - USD | 103.16% |
| 2010 Q4 | -3.59 Million USD | -112.36% |
| 2010 Q3 | -1.69 Million USD | -126.24% |
| 2010 Q1 | 1.25 Million USD | 207.92% |
| 2009 Q3 | -24.58 Million USD | 16.76% |
| 2009 Q1 | -25.03 Million USD | 70.7% |
| 2009 FY | - USD | 57.1% |
| 2009 Q4 | -1.16 Million USD | 95.27% |
| 2009 Q2 | -29.53 Million USD | -17.96% |
| 2008 Q1 | -36.49 Million USD | -427.66% |
| 2008 Q3 | -28.1 Million USD | 1.18% |
| 2008 Q4 | -85.44 Million USD | -203.99% |
| 2008 FY | - USD | -206.01% |
| 2008 Q2 | -28.44 Million USD | 22.06% |
| 2007 Q1 | -18.62 Million USD | 21.59% |
| 2007 Q3 | -12.28 Million USD | 40.1% |
| 2007 FY | - USD | 42.58% |
| 2007 Q2 | -20.5 Million USD | -10.11% |
| 2007 Q4 | -6.91 Million USD | 43.69% |
| 2006 FY | - USD | -37.65% |
| 2006 Q4 | -23.75 Million USD | -38.61% |
| 2006 Q3 | -17.13 Million USD | 52.62% |
| 2006 Q2 | -36.16 Million USD | -47.43% |
| 2006 Q1 | -24.52 Million USD | -24.77% |
| 2005 Q1 | -14.9 Million USD | -22.62% |
| 2005 Q2 | -20.18 Million USD | -35.42% |
| 2005 Q3 | -16.75 Million USD | 17.0% |
| 2005 Q4 | -19.65 Million USD | -17.35% |
| 2005 FY | - USD | -61.14% |
| 2004 Q2 | -16.55 Million USD | -526.93% |
| 2004 Q3 | -14.44 Million USD | 12.71% |
| 2004 Q4 | -12.15 Million USD | 15.86% |
| 2004 FY | - USD | 42.74% |
| 2004 Q1 | -2.64 Million USD | 93.78% |
| 2003 Q3 | -9.72 Million USD | 28.61% |
| 2003 FY | - USD | 0.17% |
| 2003 Q4 | -15.27 Million USD | -317.18% |
| 2003 Q2 | -9.8 Million USD | -8.91% |
| 2003 Q1 | -12.97 Million USD | 47.33% |
| 2002 Q3 | -19.46 Million USD | -9.02% |
| 2002 Q2 | -18.06 Million USD | 6.91% |
| 2002 FY | - USD | -199.97% |
| 2002 Q1 | -18.84 Million USD | 7.13% |
| 2002 Q4 | -24.73 Million USD | -30.5% |
| 2001 Q4 | -23.79 Million USD | -4.75% |
| 2001 Q3 | -19.54 Million USD | -131.01% |
| 2001 FY | - USD | 782.66% |
| 2001 Q2 | -21.68 Million USD | 46.15% |
| 2001 Q1 | -20.19 Million USD | 88.2% |
| 2000 Q4 | -17.83 Million USD | 235.45% |
| 2000 Q2 | -13 Million USD | 11.93% |
| 2000 Q1 | -14.77 Million USD | -46.36% |
| 2000 FY | - USD | 12.72% |
| 2000 Q3 | -16.69 Million USD | -28.3% |
| 1999 FY | - USD | 26.87% |
| 1999 Q2 | -6.6 Million USD | -7.56% |
| 1999 Q1 | -6.2 Million USD | -8.87% |
| 1999 Q4 | -10.09 Million USD | -32.22% |
| 1999 Q3 | -7.67 Million USD | -14.45% |
| 1998 FY | - USD | -62.96% |
| 1998 Q4 | -5.69 Million USD | 3.1% |
| 1998 Q3 | -5.8 Million USD | -47.26% |
| 1998 Q2 | -3.99 Million USD | 24.37% |
| 1998 Q1 | -5.27 Million USD | -22.75% |
| 1997 Q1 | -2.74 Million USD | 36.19% |
| 1997 Q4 | -4.29 Million USD | -24.14% |
| 1997 Q3 | -3.46 Million USD | -8.63% |
| 1997 Q2 | -3.18 Million USD | -16.18% |
| 1997 FY | - USD | 5.16% |
| 1996 Q2 | -3.4 Million USD | -47.83% |
| 1996 Q3 | -3.1 Million USD | 8.82% |
| 1996 Q4 | -4.3 Million USD | -38.71% |
| 1996 FY | - USD | -32.22% |
| 1996 Q1 | -2.3 Million USD | 20.69% |
| 1995 Q1 | -2.5 Million USD | 7.41% |
| 1995 Q3 | -2.3 Million USD | 4.17% |
| 1995 Q4 | -2.9 Million USD | -26.09% |
| 1995 FY | - USD | -55.17% |
| 1995 Q2 | -2.4 Million USD | 4.0% |
| 1994 Q4 | -2.7 Million USD | -107.69% |
| 1994 FY | - USD | 0.0% |
| 1994 Q2 | -1.2 Million USD | -20.0% |
| 1994 Q1 | -1 Million USD | 0.0% |
| 1994 Q3 | -1.3 Million USD | -8.33% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -26.514% |
| Alkermes plc | 495.04 Million USD | 149.108% |
| Agenus Inc. | -145.92 Million USD | -66.598% |
| Aptorum Group Limited | -9.59 Million USD | -2432.629% |
| Ardelyx, Inc. | -55.35 Million USD | -339.186% |
| Dyadic International, Inc. | -8.22 Million USD | -2854.006% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -83441.924% |
| Lantern Pharma Inc. | -15.78 Million USD | -1439.949% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1120.883% |
| Novavax, Inc. | -487.39 Million USD | 50.121% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -242.289% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -209.718% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1252.59% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -2338.874% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -323.709% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 36.019% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -908.245% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 46055.955% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -54.653% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -224.945% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1105.948% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -924.255% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -954.328% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -99.1% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 5.861% |
| AlloVir, Inc. | -190.14 Million USD | -27.853% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -38.387% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -730.908% |
| Bicycle Therapeutics plc | -183.4 Million USD | -32.556% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -46.963% |
| ChromaDex Corporation | -3.89 Million USD | -6143.118% |
| Chimerix, Inc. | -92.97 Million USD | -161.478% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -447.086% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -116.03% |
| CRISPR Therapeutics AG | -202.7 Million USD | -19.934% |
| Precision BioSciences, Inc. | -32.04 Million USD | -658.714% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -41.153% |
| Fortress Biotech, Inc. | -133.64 Million USD | -81.908% |
| Fortress Biotech, Inc. | -133.64 Million USD | -81.908% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -214.323% |
| ImmuCell Corporation | -2.5 Million USD | -9608.447% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -86.402% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1406.646% |
| Incyte Corporation | 919.42 Million USD | 126.441% |
| Innoviva, Inc. | 248.96 Million USD | 197.649% |
| IO Biotech, Inc. | -91.22 Million USD | -166.483% |
| Jaguar Health, Inc. | -33.13 Million USD | -633.775% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -59.753% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 338.98% |
| ContextLogic Inc. | -324 Million USD | 24.967% |
| MiMedx Group, Inc. | 40.51 Million USD | 700.012% |
| MEI Pharma, Inc. | 26.38 Million USD | 1021.558% |
| NextCure, Inc. | -59.03 Million USD | -311.774% |
| Onconetix, Inc. | -36.7 Million USD | -562.296% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 10977.271% |
| Opthea Limited | -200.01 Million USD | -21.542% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -8735.178% |
| Vaxcyte, Inc. | -464.88 Million USD | 47.706% |
| PDS Biotechnology Corporation | -40.08 Million USD | -506.479% |
| Precigen, Inc. | -89.22 Million USD | -172.462% |
| Pharming Group N.V. | 9.87 Million USD | 2561.345% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -52.85% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -968.039% |
| PureTech Health plc | -11.62 Million USD | -1990.883% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1331.641% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -4.116% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -908.245% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -178.069% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -739.371% |
| Acelyrin, Inc. | -381.52 Million USD | 36.28% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1886660.384% |
| Summit Therapeutics Inc. | 1 Million USD | 24386.414% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -628.17% |
| Senti Biosciences, Inc. | -61.33 Million USD | -296.353% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -116.472% |
| Elevation Oncology, Inc. | -41.46 Million USD | -486.266% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -686.652% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -3874.58% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -75634.268% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -649.105% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -2795.51% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -313.518% |
| Seer, Inc. | -97.88 Million USD | -148.36% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -290.866% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -271.922% |
| ESSA Pharma Inc. | -26.45 Million USD | -818.935% |
| GlycoMimetics, Inc. | -39.12 Million USD | -521.408% |
| GT Biopharma, Inc. | 5.97 Million USD | 4166.014% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -17.617% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -3439.706% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 380.038% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -328.352% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -374.642% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -2358.879% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 54.974% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -3431.479% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -418.772% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -2.741% |
| Aptose Biosciences Inc. | -52.26 Million USD | -365.116% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -125.635% |
| Soligenix, Inc. | -7.85 Million USD | -2995.781% |
| Century Therapeutics, Inc. | -121.2 Million USD | -100.57% |
| Kura Oncology, Inc. | -164.95 Million USD | -47.378% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -203.512% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -2310.341% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -25283.429% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -5541.843% |
| Autolus Therapeutics plc | -156.77 Million USD | -55.072% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -187.167% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -252.324% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1119.56% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -28.443% |
| GRI Bio, Inc. | -10.89 Million USD | -2130.749% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5283.577% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -98.445% |
| IGM Biosciences, Inc. | -253.35 Million USD | 4.046% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -134.225% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -537.52% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1485.731% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1444.199% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -327.666% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -126.984% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 8.605% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -25.352% |
| Verastem, Inc. | -83.16 Million USD | -192.315% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -380.715% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -53.643% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -113.085% |
| Histogen Inc. | -10.5 Million USD | -2214.643% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1602.465% |
| Surrozen, Inc. | -41.13 Million USD | -491.055% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1541.949% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 7580611.381% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -314.059% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -373.948% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1028.683% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -2815.649% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -46.392% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -393.533% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -905.988% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1514.788% |
| Apollomics, Inc. | -171.74 Million USD | -41.549% |
| Amarin Corporation plc | -50.9 Million USD | -377.603% |
| Mesoblast Limited | -61.33 Million USD | -296.385% |
| Turnstone Biologics Corp. | -56.23 Million USD | -332.313% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -69.766% |
| Synaptogenix, Inc. | -8.3 Million USD | -2826.353% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1484.895% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -285.596% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4973.75% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 56763.147% |
| Exelixis, Inc. | 196.6 Million USD | 223.654% |
| Better Therapeutics, Inc. | -38.26 Million USD | -535.375% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -71.918% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 50.908% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1960.988% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 98437.891% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -723.924% |
| Gritstone bio, Inc. | -126.86 Million USD | -91.63% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -274.097% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5977.757% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2017.472% |
| Insmed Incorporated | -654.73 Million USD | 62.87% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -10706.105% |
| MediWound Ltd. | -4.89 Million USD | -4868.465% |
| OmniAb, Inc. | -49.73 Million USD | -388.844% |
| Alector, Inc. | -142.89 Million USD | -70.133% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -184.555% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -366.187% |
| Zai Lab Limited | -366.57 Million USD | 33.681% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 16.354% |
| Aura Biosciences, Inc. | -83.69 Million USD | -190.464% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -7.928% |
| Immunic, Inc. | -99.11 Million USD | -145.285% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -84.634% |
| Veracyte, Inc. | -49.4 Million USD | -392.03% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -3341.526% |
| FibroGen, Inc. | -261.4 Million USD | 7.0% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2082.093% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3372.298% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1198.866% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 116.773% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -856.286% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 709.443% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1031.444% |
| Galecto, Inc. | -37.51 Million USD | -547.957% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -535.325% |
| Fortrea Holdings Inc. | 167.3 Million USD | 245.312% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -81.045% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -758.702% |
| XBiotech Inc. | -35.76 Million USD | -579.715% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -274.097% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -272.578% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -132.738% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -846.973% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -494.874% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 52.928% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -333.957% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -433624.644% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -108.972% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -996.58% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -3.422% |
| NexImmune, Inc. | -28.16 Million USD | -763.076% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -4299.69% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1961.579% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 105.223% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -857.416% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1975.505% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -93.178% |
| Ainos, Inc. | -8.77 Million USD | -2671.051% |
| Pluri Inc. | -20.22 Million USD | -1102.012% |
| Prothena Corporation plc | -190.1 Million USD | -27.878% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -89.634% |
| Celularity Inc. | -183.94 Million USD | -32.162% |
| Rallybio Corporation | -72.37 Million USD | -235.908% |
| Cue Biopharma, Inc. | -46.05 Million USD | -427.897% |
| MeiraGTx Holdings plc | -57.05 Million USD | -326.115% |
| Omeros Corporation | -163.61 Million USD | -48.589% |
| Humacyte, Inc. | -96.45 Million USD | -152.034% |
| Immunocore Holdings plc | -59.64 Million USD | -307.563% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1154.94% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -897.771% |
| Blueprint Medicines Corporation | -474.61 Million USD | 48.778% |
| CalciMedica, Inc. | -34.18 Million USD | -611.068% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -231.959% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -93.715% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -44.319% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 3.678% |
| Pulmatrix, Inc. | -12.64 Million USD | -1822.402% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -637.448% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -174.8% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 51.985% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -140.189% |
| Cytokinetics, Incorporated | -456.68 Million USD | 46.767% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -628.454% |
| Nutriband Inc. | -5.12 Million USD | -4646.536% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -461.811% |
| Vor Biopharma Inc. | -114.37 Million USD | -112.56% |
| Roivant Sciences Ltd. | -996.51 Million USD | 75.604% |
| Evogene Ltd. | -23.2 Million USD | -947.694% |
| ProKidney Corp. | -147.66 Million USD | -64.63% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -276.706% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -158638.875% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 57.008% |
| CorMedix Inc. | -48.88 Million USD | -397.283% |
| BioLineRx Ltd. | -57.06 Million USD | -326.048% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -117.53% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -120250.0% |
| Atai Life Sciences N.V. | -36.31 Million USD | -569.513% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -205.73% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -198.977% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 11.759% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -690.849% |
| MediciNova, Inc. | -9.87 Million USD | -2360.605% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -93.032% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -15787.259% |
| GeoVax Labs, Inc. | -26.66 Million USD | -811.579% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -8.052% |
| Biomea Fusion, Inc. | -124.62 Million USD | -95.079% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 26.407% |
| Mereo BioPharma Group plc | -26.05 Million USD | -833.017% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -27.723% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -5.725% |
| Absci Corporation | -95.45 Million USD | -154.677% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -709.682% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -126.953% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -4.125% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -963.693% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -16.971% |
| Allakos Inc. | -189.91 Million USD | -28.008% |
| Imunon, Inc. | -19.87 Million USD | -1122.978% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -124.078% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 324.426% |
| BioAtla, Inc. | -122.24 Million USD | -98.875% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1960.988% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1442.459% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 19.043% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -486.549% |
| XOMA Corporation | -39.36 Million USD | -517.619% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -144.934% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -106.636% |
| aTyr Pharma, Inc. | -52.17 Million USD | -365.919% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -190.052% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -63.564% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -3.642% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -1680.612% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -2922.854% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1346.893% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 128928.442% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 153.791% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3705.31% |
| UroGen Pharma Ltd. | -63.83 Million USD | -280.86% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -257.958% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3247.193% |
| Orgenesis Inc. | -60.71 Million USD | -300.387% |
| Entera Bio Ltd. | -8.8 Million USD | -2661.324% |
| GH Research PLC | -41.15 Million USD | -490.739% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -852.651% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -195.632% |
| Xencor, Inc. | -125.87 Million USD | -93.135% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -16941.664% |
| Replimune Group, Inc. | -230.19 Million USD | -5.608% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1106.03% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2121.778% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3705.31% |
| Portage Biotech Inc. | -18.19 Million USD | -1235.826% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -15787.259% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -132.451% |
| OncoCyte Corporation | -23.12 Million USD | -951.364% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2051.32% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2021.938% |
| Purple Biotech Ltd. | -22.22 Million USD | -993.845% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -3692.621% |
| scPharmaceuticals Inc. | -46.06 Million USD | -427.794% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1265.027% |
| HilleVax, Inc. | -132.46 Million USD | -83.524% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2186.344% |
| Tharimmune, Inc. | -9.3 Million USD | -2513.326% |
| Genprex, Inc. | -31.06 Million USD | -682.687% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -29.639% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -675.362% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -31720.288% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 161200.435% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1543841.364% |
| Savara Inc. | -59.13 Million USD | -311.119% |
| Curis, Inc. | -45.13 Million USD | -438.574% |
| Daré Bioscience, Inc. | -30.7 Million USD | -691.84% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1500.32% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -3292.98% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -809.355% |
| BeiGene, Ltd. | -1.12 Billion USD | 78.383% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1391.344% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 43.54% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -169.102% |
| Erasca, Inc. | -121.31 Million USD | -100.401% |
| bluebird bio, Inc. | -167.16 Million USD | -45.433% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5303.872% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 178.35% |
| DBV Technologies S.A. | -85.98 Million USD | -182.742% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5303.872% |
| Moderna, Inc. | -3.28 Billion USD | 92.595% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -470.553% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -4204.302% |
| Molecular Templates, Inc. | 1.43 Million USD | 17100.49% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -306.18% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 25.484% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -77.335% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -413.252% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -74.854% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -18.093% |
| MacroGenics, Inc. | 2.01 Million USD | 12152.9% |
| RenovoRx, Inc. | -11.39 Million USD | -2034.39% |
| Adicet Bio, Inc. | -136.53 Million USD | -78.055% |
| Prime Medicine, Inc. | -193.75 Million USD | -25.469% |
| Aditxt, Inc. | -25.45 Million USD | -854.935% |
| Adagene Inc. | -14.95 Million USD | -1526.048% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3225.633% |
| Quantum-Si incorporated | -91.8 Million USD | -164.811% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 134.125% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 292.248% |
| SciSparc Ltd. | -5.28 Million USD | -4502.556% |
| Vericel Corporation | 2.86 Million USD | 8588.373% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -255243.038% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1020.751% |
| Generation Bio Co. | -133.3 Million USD | -82.376% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -192.794% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -182.607% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -6.891% |
| Invivyd, Inc. | -196.61 Million USD | -23.646% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 35.025% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -2521.157% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 995.29% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2263.704% |
| 2seventy bio, Inc. | -206.41 Million USD | -17.774% |
| ADMA Biologics, Inc. | 5.12 Million USD | 4848.184% |
| Clene Inc. | -43.24 Million USD | -462.214% |
| Capricor Therapeutics, Inc. | -23 Million USD | -956.575% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -401.489% |
| GeoVax Labs, Inc. | -26.66 Million USD | -811.579% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 18.847% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -561.888% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1131.294% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 5051.006% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -648.436% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -53.473% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 64.474% |
| Evaxion Biotech A/S | -21.4 Million USD | -1035.855% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -266.042% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -11.687% |
| Trevena, Inc. | -35.28 Million USD | -588.923% |
| Surrozen, Inc. | -41.13 Million USD | -491.055% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -205.442% |
| Cingulate Inc. | -22.95 Million USD | -959.196% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -3158.37% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -552.059% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -2855.216% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -137.72% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -258.422% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -316.479% |
| Clearmind Medicine Inc. | -8.71 Million USD | -2690.913% |
| Kronos Bio, Inc. | -121.83 Million USD | -99.546% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -227.012% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -9857.631% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -141.113% |
| Statera Biopharma, Inc. | 38.93 Million USD | 724.393% |
| ImmunityBio, Inc. | -436.18 Million USD | 44.265% |
| Korro Bio, Inc. | -80.9 Million USD | -200.488% |
| Kineta, Inc. | -15.71 Million USD | -1447.073% |
| BioVie Inc. | -31.95 Million USD | -660.893% |
| Codexis, Inc. | -49.28 Million USD | -393.288% |
| Celularity Inc. | -183.94 Million USD | -32.162% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -9.75% |
| Celcuity Inc. | -58.3 Million USD | -316.922% |
| Virax Biolabs Group Limited | -6.6 Million USD | -3578.343% |
| Cibus, Inc. | -314.58 Million USD | 22.721% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -620.68% |
| IN8bio, Inc. | -28.5 Million USD | -752.887% |
| Kodiak Sciences Inc. | -259.02 Million USD | 6.145% |
| Annexon, Inc. | -141.57 Million USD | -71.716% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -115.905% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -278.695% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -769.637% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -5.694% |
| Eyenovia, Inc. | -24.1 Million USD | -908.49% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 642.843% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -74933.025% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -229.395% |
| Arcellx, Inc. | -64.14 Million USD | -278.996% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -440.07% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -96.886% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -687.213% |
| Moolec Science SA | -52.07 Million USD | -366.835% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -371.083% |
| Geron Corporation | -174.78 Million USD | -39.092% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -501.497% |
| Royalty Pharma plc | 1.88 Billion USD | 112.881% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -103.279% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2507.254% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1072.122% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -46.379% |
| Humacyte, Inc. | -96.45 Million USD | -152.034% |
| Structure Therapeutics Inc. | -102.45 Million USD | -137.272% |
| 89bio, Inc. | -134.46 Million USD | -80.798% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -208.218% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 6099.679% |
| Genelux Corporation | -24.16 Million USD | -906.029% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -619.251% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -48.722% |
| Notable Labs, Ltd. | -14.4 Million USD | -1588.243% |
| Liquidia Corporation | -70.05 Million USD | -247.043% |
| Mustang Bio, Inc. | -48.06 Million USD | -405.809% |
| Immunovant, Inc. | -269.97 Million USD | 9.953% |
| Quantum-Si incorporated | -91.8 Million USD | -164.811% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -242.472% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1159.1% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -138.312% |
| Acasti Pharma Inc. | -11.3 Million USD | -2051.199% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -992.457% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1485.731% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -15.483% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -5592.915% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1430.901% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -744.826% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -556.514% |
| PepGen Inc. | -83.58 Million USD | -190.86% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -723.98% |
| United Therapeutics Corporation | 1.38 Billion USD | 117.53% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -961.742% |
| Solid Biosciences Inc. | -93.43 Million USD | -160.191% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -4994.729% |
| Immuneering Corporation | -58.06 Million USD | -318.711% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 7580611.381% |
| Silo Pharma, Inc. | -3.62 Million USD | -6604.155% |
| Belite Bio, Inc | -31.52 Million USD | -671.058% |
| XOMA Corporation | -39.36 Million USD | -517.619% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -260.442% |
| Bionomics Limited | -9.83 Million USD | -2371.354% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -189.465% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -602.5% |
| uniQure N.V. | -253.1 Million USD | 3.948% |
| Cassava Sciences, Inc. | -95.68 Million USD | -154.065% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3225.633% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -87.722% |
| Forte Biosciences, Inc. | -32.47 Million USD | -648.551% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -2919.785% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -761.501% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -74933.025% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2082.093% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1428.879% |
| Altimmune, Inc. | -87.93 Million USD | -176.462% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -164.02% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -602.5% |
| Compugen Ltd. | -12.51 Million USD | -1842.37% |
| Peak Bio, Inc. | -1356.23 USD | -17925104.427% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -400.241% |
| Benitec Biopharma Inc. | -22.49 Million USD | -980.956% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -0.332% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -751.722% |
| Zura Bio Limited | -60.56 Million USD | -301.412% |
| PolyPid Ltd. | -20.26 Million USD | -1099.758% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1457.081% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -751.722% |
| Instil Bio, Inc. | -146.12 Million USD | -66.373% |
| argenx SE | -216.02 Million USD | -12.538% |
| Immunome, Inc. | -28.27 Million USD | -759.917% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -401.531% |
| Verona Pharma plc | -52.46 Million USD | -363.347% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -156.518% |
| Shattuck Labs, Inc. | -87.61 Million USD | -177.472% |
| CervoMed Inc. | -2.17 Million USD | -11093.421% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -98.87% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1815.284% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -404.644% |
| Moolec Science SA | -52.07 Million USD | -366.835% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1318.362% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -86.445% |
| AnaptysBio, Inc. | -143.16 Million USD | -69.81% |
| Design Therapeutics, Inc. | -66.32 Million USD | -266.539% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -200.18% |
| NeurAxis, Inc. | -6.66 Million USD | -3547.793% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -543.992% |
| Lumos Pharma, Inc. | -36.57 Million USD | -564.772% |
| Achilles Therapeutics plc | -70.44 Million USD | -245.117% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -156.518% |
| 180 Life Sciences Corp. | -22.13 Million USD | -998.341% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 4270.47% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -9857.631% |
| Nutriband Inc. | -5.12 Million USD | -4646.536% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -121.514% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -338.568% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -380.924% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -272.424% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -349.283% |
| Palisade Bio, Inc. | -12.28 Million USD | -1879.537% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -435.761% |
| Beam Therapeutics Inc. | -156.47 Million USD | -55.367% |
| Neurogene Inc. | -52.28 Million USD | -364.956% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -78.113% |
| AEON Biopharma, Inc. | -48.36 Million USD | -402.692% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -161.355% |
| Sesen Bio, Inc. | -50.84 Million USD | -378.181% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -196.718% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1868.474% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 43.124% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -131.097% |
| Athira Pharma, Inc. | -116.7 Million USD | -108.313% |
| Vaccinex, Inc. | -19.74 Million USD | -1131.046% |
| HCW Biologics Inc. | -23.57 Million USD | -931.161% |
| XOMA Corporation | -39.36 Million USD | -517.619% |
| Arvinas, Inc. | -394.8 Million USD | 38.423% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 128928.442% |
| Merus N.V. | -149.2 Million USD | -62.933% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -160.035% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -677.694% |
| Rezolute, Inc. | -68.42 Million USD | -255.3% |
| Clene Inc. | -43.24 Million USD | -462.214% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1476.346% |
| BeyondSpring Inc. | -21.54 Million USD | -1028.63% |
| Synlogic, Inc. | -55.16 Million USD | -340.723% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -1911.976% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2184.411% |
| Peak Bio, Inc. | -1356.23 USD | -17925104.427% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -648.828% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1457.836% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -105.287% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 28.78% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -5177.555% |
| MannKind Corporation | 15.12 Million USD | 1706.894% |
| Ikena Oncology, Inc. | -74.39 Million USD | -226.77% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1830.493% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1295.981% |
| Gossamer Bio, Inc. | -172.15 Million USD | -41.216% |
| CohBar, Inc. | -12.06 Million USD | -1914.85% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -853.024% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -709.682% |
| Legend Biotech Corporation | -477.87 Million USD | 49.127% |
| Mural Oncology plc | -192.72 Million USD | -26.145% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -113.151% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1405.748% |
| Disc Medicine, Inc. | -91.02 Million USD | -167.077% |
| Champions Oncology, Inc. | -5.05 Million USD | -4710.19% |
| REGENXBIO Inc. | -239.46 Million USD | -1.521% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2168.173% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -336.019% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -527.077% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -115.509% |
| Vaxart, Inc. | -74.72 Million USD | -225.344% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -590.482% |
| Cellectis S.A. | -98.09 Million USD | -147.828% |
| Longeveron Inc. | -20.06 Million USD | -1111.899% |
| Repare Therapeutics Inc. | -114.27 Million USD | -112.742% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 44.647% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -224.957% |
| Revolution Medicines, Inc. | -430.58 Million USD | 43.54% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -3765.591% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -689.59% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -225.924% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 5058.332% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2117.118% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 105.279% |
| Denali Therapeutics Inc. | -179.97 Million USD | -35.08% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -255243.038% |
| Veru Inc. | -89.97 Million USD | -170.192% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -804.483% |
| Cingulate Inc. | -22.95 Million USD | -959.196% |
| Passage Bio, Inc. | -98.34 Million USD | -147.208% |
| Context Therapeutics Inc. | -25.06 Million USD | -870.078% |
| Exicure, Inc. | -15.53 Million USD | -1464.496% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -17.976% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -557.472% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -3977.201% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -44.308% |
| Nuvalent, Inc. | -149.49 Million USD | -62.622% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -2889.358% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -183.031% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -705.577% |
| OmniAb, Inc. | -49.73 Million USD | -388.844% |
| Anew Medical, Inc. | -1.3 Million USD | -18588.463% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1866.249% |
| Lipocine Inc. | -16.32 Million USD | -1389.383% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -264.642% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -227.183% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -537.52% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -523.128% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -995.916% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 55.399% |
| Ocugen, Inc. | -64.82 Million USD | -275.009% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -162.62% |
| Q32 Bio Inc. | -86.5 Million USD | -181.042% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1336.208% |
| Alumis Inc. Common Stock | -156.89 Million USD | -54.954% |
| Equillium, Inc. | -12.13 Million USD | -1902.859% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -315.767% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2976.0% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1188.942% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -420.661% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -128.602% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1259.158% |
| Dominari Holdings Inc. | -22.44 Million USD | -983.365% |
| Edesa Biotech, Inc. | -8.19 Million USD | -2868.288% |
| vTv Therapeutics Inc. | -25.41 Million USD | -856.662% |
| Bio-Techne Corporation | 326.66 Million USD | 174.421% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 36.833% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 212.347% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -85.425% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -549.48% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -60.89% |
| Nkarta, Inc. | -120.48 Million USD | -101.78% |
| BioCardia, Inc. | -11.56 Million USD | -2003.002% |
| Iterum Therapeutics plc | -34.58 Million USD | -603.028% |